Roche blood test could help 'personalize' cancer immunotherapy

MADRID (Reuters) – A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping to predict which patients may respond best to some immunotherapies.


Source: Reuters Health News